Cargando…

Putative markers for the detection of breast carcinoma cells in blood.

The aim of this study was to investigate certain genes for their suitability as molecular markers for detection of breast carcinoma cells using the reverse transcriptase-polymerase chain reaction (RT-PCR). RNA was prepared from MCF-7 breast carcinoma cells and peripheral blood leucocytes of healthy...

Descripción completa

Detalles Bibliográficos
Autores principales: Eltahir, E. M., Mallinson, D. S., Birnie, G. D., Hagan, C., George, W. D., Purushotham, A. D.
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 1998
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2150149/
https://www.ncbi.nlm.nih.gov/pubmed/9579823
_version_ 1782144584422260736
author Eltahir, E. M.
Mallinson, D. S.
Birnie, G. D.
Hagan, C.
George, W. D.
Purushotham, A. D.
author_facet Eltahir, E. M.
Mallinson, D. S.
Birnie, G. D.
Hagan, C.
George, W. D.
Purushotham, A. D.
author_sort Eltahir, E. M.
collection PubMed
description The aim of this study was to investigate certain genes for their suitability as molecular markers for detection of breast carcinoma cells using the reverse transcriptase-polymerase chain reaction (RT-PCR). RNA was prepared from MCF-7 breast carcinoma cells and peripheral blood leucocytes of healthy female volunteers. This RNA was screened for mRNA of MUC1, cytokeratin 19 (CK19) and CD44 (exons 8-11) by RT-PCR and the results validated by Southern blots. Variable degrees of expression of MUC1 and CD44 (exons 8-11) were detected in normal peripheral blood, rendering these genes non-specific for epithelial cells and therefore unsuitable for use as markers to detect breast carcinoma cells. Although CK19 mRNA was apparently specific, it was deemed unsuitable for use as a marker of breast cancer cells in light of its limited sensitivity. Furthermore, an attempt at using nested primers to increase sensitivity resulted in CK19 mRNA being detected after two amplification rounds in blood from healthy volunteers. IMAGES:
format Text
id pubmed-2150149
institution National Center for Biotechnology Information
language English
publishDate 1998
publisher Nature Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-21501492009-09-10 Putative markers for the detection of breast carcinoma cells in blood. Eltahir, E. M. Mallinson, D. S. Birnie, G. D. Hagan, C. George, W. D. Purushotham, A. D. Br J Cancer Research Article The aim of this study was to investigate certain genes for their suitability as molecular markers for detection of breast carcinoma cells using the reverse transcriptase-polymerase chain reaction (RT-PCR). RNA was prepared from MCF-7 breast carcinoma cells and peripheral blood leucocytes of healthy female volunteers. This RNA was screened for mRNA of MUC1, cytokeratin 19 (CK19) and CD44 (exons 8-11) by RT-PCR and the results validated by Southern blots. Variable degrees of expression of MUC1 and CD44 (exons 8-11) were detected in normal peripheral blood, rendering these genes non-specific for epithelial cells and therefore unsuitable for use as markers to detect breast carcinoma cells. Although CK19 mRNA was apparently specific, it was deemed unsuitable for use as a marker of breast cancer cells in light of its limited sensitivity. Furthermore, an attempt at using nested primers to increase sensitivity resulted in CK19 mRNA being detected after two amplification rounds in blood from healthy volunteers. IMAGES: Nature Publishing Group 1998-04 /pmc/articles/PMC2150149/ /pubmed/9579823 Text en https://creativecommons.org/licenses/by/4.0/This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit https://creativecommons.org/licenses/by/4.0/.
spellingShingle Research Article
Eltahir, E. M.
Mallinson, D. S.
Birnie, G. D.
Hagan, C.
George, W. D.
Purushotham, A. D.
Putative markers for the detection of breast carcinoma cells in blood.
title Putative markers for the detection of breast carcinoma cells in blood.
title_full Putative markers for the detection of breast carcinoma cells in blood.
title_fullStr Putative markers for the detection of breast carcinoma cells in blood.
title_full_unstemmed Putative markers for the detection of breast carcinoma cells in blood.
title_short Putative markers for the detection of breast carcinoma cells in blood.
title_sort putative markers for the detection of breast carcinoma cells in blood.
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2150149/
https://www.ncbi.nlm.nih.gov/pubmed/9579823
work_keys_str_mv AT eltahirem putativemarkersforthedetectionofbreastcarcinomacellsinblood
AT mallinsonds putativemarkersforthedetectionofbreastcarcinomacellsinblood
AT birniegd putativemarkersforthedetectionofbreastcarcinomacellsinblood
AT haganc putativemarkersforthedetectionofbreastcarcinomacellsinblood
AT georgewd putativemarkersforthedetectionofbreastcarcinomacellsinblood
AT purushothamad putativemarkersforthedetectionofbreastcarcinomacellsinblood